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ABSTRACT 
India has HBV carrier rate of 3.0% approximately with a high prevalence rate in the villages and remote areas. The variation in social, ethnic, 
economic, habits and other health conditions in different areas may explain the difference in outcome of the disease. High-risk groups (especially 
tribals) also harbor significant disease burden and have a high prevalence of occult infection, supporting the potential of unknowingly spreading 
the disease. Hence identifying and targeting that population for public healthcare measure is the necessity to control the disease and promoting 
hepatitis B vaccination around the country. The present study was carried to out to elucidate epidemiology of chronic hepatitis B in the patients 
of Majeedia Unani Hospital New Delhi to locate high risk groups and areas for health education regarding lifestyle, preventive measures, early 
disease detection and proper adherence to drugs and of health care workers on adoption of proper precautions while carrying out their duties, 
and aggressive vaccination strategies thereafter.  
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INTRODUCTION 
Chronic hepatitis B (CHB) is a major global health problem 
affecting 240 million people worldwide particularly common 
in low- and middle-income countries (LMICs) such as India. 
Every year on an average 650 000 people die due to CHB 
induced complications such as cirrhosis, liver failure and 
hepatocellular carcinoma. 1 More than 37 million people are 
chronically infection with hepatitis B virus (HBV) in India, 
thus contributing a large proportion of this HBV burden. 2 
Due to scarcity in routine testing and vaccination, many 
people in India are unaware of their disease status which put 
them at the risk of life threatening end stage liver diseases 
even before initial diagnosis takes place. 3 
Majeedia Unani hospital (MUH) is one of the pioneer 
hospitals located in the capital of India to provide Unani 
medical treatment facilities under collaborated functioning 
of School of Unani medical education and research, Jamia 
Hamdard (Hamdard University). MUH has cost-efficient and 
comprehensive facilities for diagnosis, treatment and 
patient-care related to infectious disorders like hepatitis B. 
Thus, MUH attends huge number of patients with liver 
disorders particularly hepatitis B from all over the country. 
In the present study, we aimed to explore the socio-
demographic characteristics of 30 random patients of 
chronic hepatitis B and to scrutinize them to ascertain the 
probable mode of transmission.  
MATERIAL AND METHODS  
Ethical consideration  
The proposal was approved by Institutional ethics 
committee of Jamia Hamdard (JH 1EC/ 1530 HOURS/ 
AUGUST 12/15) and was carried out in accordance with 
Declaration of Helsinki, ICMR and GCP guidelines. 
[CTRI/2017/11/010386] 
Study participants  
Study was carried out in Majeedia Unani Hospital New Delhi, 
India. Patients were confirmed for their CHB status, if they 
were positive for HBsAg more than 6 months. 30 patients of 
CHB aged 18-60y were selected through random assignment 
and were studied after taking their informed consent to 
participate in the study. Patients were asked a set of 
questions related to their disease and documented in the 
case record form.  
 
Ansari et al                                                                                                                 Journal of Drug Delivery & Therapeutics. 2019; 9(2):237-243 
ISSN: 2250-1177                                                                                     [238]                                                                                     CODEN (USA): JDDTAO 
Outcome measures 
Patients were distributed into different group according to 
their HBeAg status, age, gender, religion, marital status, body 
mass index, socio-economic status, occupation, dietary 
habits, state-domicile, habits/ addiction, chronicity of the 
disease and plausible route of HBV transmission for analysis 
of epidemiology of the disease.  
Statistical analysis 
Normal-distributed continuous variables were given as mean 
± standard deviation (SD). Continuous variables were 
compared by unpaired and paired 't' test through GraphPad 
Prism, version 7.00 for windows created on March 31, 2016. 
Differences were considered significant when the p value 
was less than 0.05. Test results were ranked as: ns - Non 
significant p>0.05, *p < 0.05 significant, **p < 0.01 very 
significant, ***p < 0.001 extremely significant. 
RESULTS AND DISCUSSION  
Distribution of the patients according to HBeAg status 
Out of total 30 patients, 14 (46.66%) were HBeAg positive 
while 16 (53.33%) patients were HBeAg negative.  
Distribution of patients according to their age  
The overall mean±SD age of the total study patients was 
30.2±SD 11.20 y. Mean±SD age in HBeAg positive and 
negative group were 29.64±SD 11.47 y and 30.68±SD 11.31 y 
respectively. The mean age was comparable in both HBeAg 
positive and negative group (p=0.8039). Table 1 and figure 1 
shows that in HBeAg positive group, maximum patients 
(42.85%) belonged to the age group of 18-25 y & 26-33 y. 
While in HBeAg negative group, 50% of the patients 
belonged to the age group 18-25 y.  
In total patients, majority of the (46.66%) patients belonged 
to the age group 18-25 y and no (0%) patient was in the age 
group of 42-49 y. 3 (10%) patients and 1 (3.33%) patient 
belonged to the age group of 50-56 y and 57-60 y 
respectively. Regarding Asian countries including India, HBV 
infection is mainly acquired during perinatal and early 
childhood period. Most of the infected patients are diagnosed 
positive for HBsAg positive when they have a bout of damage 
of liver or jaundice or develop physical symptoms which 
usually occur during an age of 15-35 y 4 (generally during 
2nd-4th decades of life). 5  In India, most of the patients have 
non-specific gastro-intestinal symptoms and diagnosed 
HBsAg positive at their working age of 25-40 y during 
routine medico-legal checkups for international jobs. This is 
what we have observed throughout the study. This could be 
a reason, most of the study patients belonged to the age 
group of 18-25 y. After 18-25 y group, maximum patients 
belonged to 26-33 y and 34-41 y age group. 
In a meta-analysis of 79 studies on CHB, the mean age of 
patients in these studies mainly ranges between 25-45 y 
(inclusion criteria of age 18-69 y in most of the studies). 6 In 
our study, mean age of our patients was 30.2 y (inclusion 
criteria of age 18-60 y). This shows CHB is more commonly 
diagnosed at this age and our study had similar demographic 
characteristics like other studies on CHB. 
   
 
Figure 1: Demographic distribution of patients according to age (y) 
Table 1: Demographic distribution of patients according to age (y) 
Age  HBeAg Positive  
Patients (n=14) 
HBeAg Negative 
Patients (n=16) 
Total  
Patients (n=30) 
p Value 
(Unpaired “t test) 
No.  % No. % No. % HBeAg Positive  
Vs.  
HBeAg 
Negative 
p>0.05 
18-25 6 42.85% 8 50% 14 46.66% 
26-33 6 42.85% 3 18.75% 9 30% 
34-41 0 0 3 18.75% 3 10% 
42-49 0 0 0 0 0 0% 
50-56 1 7.14% 2 12.5% 3 10% 
57-60 1 7.14% 0 0 1 3.33% 
Mean Age 29.64 (SD 11.47)  30.68 (SD 11.31)  30.2 (SD 11.20)  
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Distribution of patients according to gender, religion, 
dietary habbits and marital status  
Majority of the patients were men, 12 (85.71%) in the HBeAg 
positive (n=14) and 09 (56.25%) in the HBeAg negative 
group (n=16). Among total patients, 21 (70%) were men and 
rest 09 (30%) were women. [Figure 2] Gender, age and 
ethnicity greatly affect the course of CHB and efficacy of 
treatment. An immune compromised male of > 40 y of age 
with risky HBV DNA levels & HBeAg status, are at more risk 
for cirrhosis and HCC. 7, 8 
All the 30 (100%) patients were non-vegetarian. This might 
be due to majority of the Muslims (98.33%) in the study. 
However, dietary preferences are now changing and its 
relation with religion is getting obscure.  
Among total 30 patients, 28 (98.33%) were Muslims and rest 
02 (6.66%) were Hindus. It is because of dissonances among 
the people with different religious background.  Among total 
30 patients, 21 (70%) were married and 09 (30%) were 
unmarried. No patient gave positive history of hepatitis B in 
his/ her partner. 
  
 
Figure 2: Distribution of patients according to gender 
Distribution of patients according to body mass index (BMI) 
 
Figure 3: Distribution of patients according to BMI (kg/m2) 
 
Majority of the patients, 09 (64.28%) in HBeAg positive 
group (n=14) and 13 (81.25%) in HBeAg negative group 
(n=16) were healthy as per BMI range of 18.5-24.9 kg/m2. 4 
(28.57%) patients in HBeAg positive group and 1 (6.25%) 
patient in HBeAg negative group were under-weight with 
BMI of <18.5 kg/m2. [Figure 3] There was no statistical 
difference in BMI of  HBeAg positive and negative group. 
(p>0.05) 
Distribution of patients according to socio-economic 
status 
Out of total 30 patients, 17 (56.66%) patients belonged to 
LIG. 11 (36.66%) and 2 (6.66%) patients in this study 
belonged to MIG and HIG respectively. [Figure 4] 
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†LIG: Upto or <1,50,000;#MIG: 1,50,000 to 5,50,000:  γHIG: 
>5,50,000 Lacs per annum 
Figure 4: Distribution of patients according to socio-
economic status 
Through other studies and our observations throughout this 
study depicted that close body contact, unhygienic practices 
and lack of awareness, screening and vaccination program 
for HBV, makes HBV more prevalent in low-income, remote 
village areas. 9, 10 Possibility of majority of LIG in this study 
can be attributed to MUH where mainly low income patients 
of hepatitis B came for treatment who either got no relief or 
other treatments were not so much affordable.  
Distribution of patients according to states of India and 
districts of Uttar Pradesh (UP) 
Out of total 30 patients, 20 (66.66%) were natives of state 
“Uttar Pradesh”. [Figure 5] Further exploration was done to 
locate the districts of UP where maximum study patients 
belonged. Radar in the figure 6 shows that the maximum 
patients belonged to the district “Sambhal” (25%), then 
“Bijnor”, “Rampur” “Meerut”, “Hapur”, “Badaun” etc. This 
analysis was done to possibly notify districts like Sambhal 
and Rampur as a target for awareness, screening, prevention 
and treatment strategies which are a hub of viral hepatitis 
patients. MUH has been treating large no. of patients from 
these two districts. Distance and referral from other relived 
patients could also be the other reasons for visiting to MUH.  
Out of total 30 patients, 4 (13.33%) and 6 (20%) patients 
belonged to the state “Bihar” and “Delhi” respectively. 
 
Figure 5: Distribution of patients according to states of 
India 
 
Figure 6: Demographic distribution of patients 
according to various states of UP 
Distribution of patients according to occupation and 
habit/ addiction 
Out of total 30 patients, study was consisted of 7 (23.33%) 
housewives, 5 (16.66%) farmers, 5 (16.66%) students, 4 
(13.33%) mechanics and electricians, 2 (6.66%) chefs, 2 
(6.66%) business men, 1 (3.33%) doctor, 1 (3.33%) tailor,  1 
(3.33%) sales manager and 1 (3.33%) painter. [Figure 7]  
 
Figure 7: Distribution of patients according to 
occupation 
2 (14.28%) patients in HBeAg positive group (n=14) and 2 
(12.5%) patients in HBeAg negative group (n=16) were 
smokers. (p>0.99) Similarly tobacco chewers were 2 
(14.28%) patients in HBeAg positive group (n=14) and 2 
(12.5%) patients in HBeAg negative group (n=16). (p>0.99) 
Only HBeAg negative group had 1 (6.25%) alcoholic patient, 
HBeAg positive group had no alcoholic patient. (p>0.99) 
[Figure 8] Since alcohol, smoking and tobacco chewing play a 
role in the outcome of the disease in HBV infection. 7 
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Figure 8: Distribution of patients according to addiction/ 
habit 
Distribution of patients according to temperament 
(mizaj) 
Unani System of Medicine conceptualize that each person 
has a own unique temperament (mizaj) according to their 
humoral constitution, lifestyle and environment. The 
interaction between four elements in the body produces 
various states which determine the temperament of an 
individual. Disturbance in the temperament of the body (sue-
mizaj) is the root of disease. So, each disease produce an 
abnormal temperament corresponding to a humour which 
needs to be corrected. Thus, we have also evaluated our 
patients for temperament to analyze the patients as per 
Unani concepts.  
Out of total 30 patients, majority of the patients, 19 (63.33%) 
were bilious (safrawi) in temperament followed by 9 (30%) 
patients of sanguineous (damwi) temperament followed by 
melancholic (saudawi) temperament in 2 (6.66%) patients. 
No patient (0%) had phlegmatic (balghami) temperament at 
baseline. [Table 2] 10% of the patients were overweight as 
shown in figure 3 but not carrying phlegmatic temperament. 
There may be the possibility of development of abnormal 
temperament (sue-mizaj) due to disease condition. Patients 
when distributed as per their HBeAg positive and negative 
status, there was no statistical significance in both the group 
regarding temperament as shown in table 2. (p>0.05)  
These findings are in cohesion with the fundamental basis of 
temperament as per documented in Unani literature. 11-14 
Distribution of patients according to chronicity of CHB 
Out of total 30 patients, majority 18 (60%) patients have 
been HBsAg positive from 6 mo to 1 y followed by 6 (20%) 
patients who had history of CHB from 1-2 y. 5 (16.66%) 
patients and 1 (3.33%) patient had CHB from 2-5 y and >5 y 
respectively. Negative status of anti-HBc IgM of patients also 
favored diagnosis of CHB. [Figure 9] 
 
Table 2: Distribution of patients according to temperament (mizaj) 
 
Temperament HBeAg Positive 
(n=14) 
HBeAg Negative 
(n=16) 
Total 
(n=30) 
†p Value 
(Unpaired “t” 
test) 
 
No. of 
Patients 
% No. of 
Patients 
% No. of 
Patients 
% 
Sanguinous (Damwi) 5 35.71 4 13.33 9 30 p=0.69 
p>0.99 
p>0.71 
p>0.99 
Phlegmatic (Balghami) 0 0 0 0 0 0 
Bilious (Safrawi) 8 57.14 11 50 19 63.33 
Melancholic (Saudawi) 1 7.14 1 6.25 2 6.66 
      †HBeAg Positive Vs. Negative 
 
Figure 9: Distribution of patients according to chronicity of CHB 
 
Distribution of patients according to past history of 
treatment 
24 (80%) patients were antiviral treatment naïve while 6 
(20%) patients had history of antiviral treatment but their 
viral load increased instead or had no relief in their 
condition and left medicine due to adverse effects.  
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Ascertaining route of HBV transmission  
Out of total 30 patients, 16 (53.33%) patients had positive 
history of hepatitis B in family. But this depiction can only 
provide an assumption as family members of rest of the 
cases might not be screened for hepatitis B, thus no positive 
history were received from them.  68.75% of the patients 
reported positive history of hepatitis B in sibilings (brothers 
and sisters) and 31.25% of patients reported positive history 
in their mother while 6.25% of patients reported in father. 
This substantiate the perinatal and early childhood mode of 
transmission of HBV infection in India. 7, 15 However 68.75% 
patients with positive history in siblings may have HBsAg 
positive mother which might not have been screened for 
HBV.  
Positive history was also found in the cousins of 12.5% 
patients. These type of history is commonly observed in low 
economy, congested, village and endemic areas.  In India, 
especially in village areas where more than two or three 
families are living under the same roof. So positive history, 
observed in cousins could be plausibly due to close body 
contact and unhygienic practices in low income families 
living in a congested area, are also a major route of 
transmission leading to early childhood infection. 3, 16 Here, it 
is also necessary to remember that HBV is highly infectious. 
1, 17 
Apart from these route of transmission, history of shaving at 
barber shop was found in 10 (33.33%) patients. In villages, 
one shaving blade is used in multiple persons, which could 
be a plausible assumption as route of transmission in rest of 
the cases in whom family history and other possible ways of 
transmission were not found. Through our observations and 
exhaustive interaction with patients, we have included this 
mode of subcutaneous transmission in our study patients. It 
is also mentioned above & in figure 5 & 6 that 66.66% of the 
patients belonged to various endemic low economy districts 
of UP. 3 
In some remote areas, practice of using the same IV/ IM 
syringe in multiple patients was also reported by 3 (10%) 
patients. As per data available, the major modes of HBV 
transmission in India are through perinatal, percutaneous 
and sexual routes. 1, 3 [Table 3; Figure 10; Table 4; Figure 11) 
 
Table 3: Distribution of patients according to possible route of HBV transmission 
 
 
 
Family 
History 
Outside  
Shaving 
Unsterile 
Injections  
Blood 
Transfusion 
Dialysis Sexual Unknown 
No. of Patients 16 10 3 0 0 0 1 
Percentage 53.33 33.33 10 0 0 0 3.33 
 
 
 
Figure 10: Distribution of patients according to mode of transmission 
 
Table 4: Distribution of patients according to hepatitis B in family members based on history 
(n=16) 
Family History Mother Father Brother & Sister Cousin Daughter 
No. of Patients 5 1 11 2 1 
Percentage 31.25 6.25 68.75 12.5 6.25 
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Figure 11: Distribution of patients according to hepatitis B in family 
 
CONCLUSION  
The observations and statistics of the study infers that 
chronic hepatitis B is mostly diagnosed at 25-45 years of the 
age. Beside the prevalent vertical mode of transmission, 
horizontal transmission through used syringes, needles and 
blades are still present in remote areas and villages. The 
disease is more common in lower socio-economic areas and 
people due to unhygienic practices, congested living and lack 
of awareness, early diagnostic facilities and vaccination.  It is 
important to conduct multicentric population based studies 
to better elucidate the epidemiology of HBV and identify high 
prevalence areas and simultaneously focus on improving 
public health measures to prevent disease transmission and 
decrease the burden of the disease. 
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